The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Differentiation & Death
The EMBO Journal (2004) 23, 2146–2155, doi:10.1038/sj.emboj.7600225
Published online 6 May 2004
Bcl-xL sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers
Seon-Yong Jeong1, 3, Brigitte Gaume1, 3, Yang-Ja Lee1, Yi-Te Hsu2, Seung-Wook Ryu1, Soo-Han Yoon1 and Richard J Youle1
1 Biochemistry Section, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
2 Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA

To whom correspondence should be addressed
Richard J Youle, Biochemistry Section, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Building 10, Room 4N-258, MSC 1414, 10 Center Drive, Bethesda, MD 20892-1414, USA. Tel.: +1 301 496 6628; Fax: +1 301 402 0380; E-mail: youle@helix.nih.gov, youler@ninds.nih.gov

3 These authors contributed equally to this work

Received 30 September 2003; Accepted 6 April 2004; Published online 6 May 2004.
Abstract
Bcl-xL is a potent inhibitor of apoptosis. While Bcl-xL can be bound to mitochondria, a substantial fraction, depending on the cell type or tissue, is found in the cytosol of healthy cells. Gel filtration and crosslinking experiments reveal that, unlike monomeric Bax, Bcl-xL migrates in a complex of approximately 50 kDa in the cytosol. Co-immunoprecipitation experiments indicate that Bcl-xL in the cytosol forms homodimers. The C-terminal hydrophobic tails of two Bcl-xL molecules are involved in homodimer formation, and analysis of mutants demonstrates that the C-terminal lysine residue and the G138 residue lining the BH3-binding pocket are required for homodimerization. The flexible loop preceding the C-terminal tail in Bcl-xL is longer than that of several monomeric Bcl-2 family members and is a requisite for the homodimer formation. Bad binding to Bcl-xL dissociates the homodimers and triggers Bcl-xL binding to mitochondrial membranes. The C-terminal tail of Bcl-xL is also required to mediate Bcl-xL/Bax heterodimer formation. Both mitochondrial import and antiapoptotic activity of different Bcl-xL mutants correlate with their ability to form homodimers.
Keywords: apoptosis, Bad, Bax, Bcl-2, Bcl-xL, dimerization
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Blueprints for life or death

Nature Immunology News and Views (01 May 2001)

Apoptosis Stabbed in the BAX

Nature News and Views (23 Oct 2008)

See all 3 matches for News And Views

RESEARCH

Specificity of SN50 for NF-κB?

Nature Immunology Correspondence (01 Jun 2001)

Toward fluorescence nanoscopy

Nature Biotechnology Research (01 Nov 2003)

See all 38 matches for Research

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2004 by the European Molecular Biology Organization